Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology … B Bozkurt, AJS Coats, H Tsutsui, M Abdelhamid, S Adamopoulos, N Albert, ... Journal of cardiac failure 27 (4), 387-413, 2021 | 1617 | 2021 |
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial AA Voors, CE Angermann, JR Teerlink, SP Collins, M Kosiborod, J Biegus, ... Nature medicine 28 (3), 568-574, 2022 | 542 | 2022 |
JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure―digest version― H Tsutsui, M Isobe, H Ito, K Okumura, M Ono, M Kitakaze, K Kinugawa, ... Circulation Journal 83 (10), 2084-2184, 2019 | 467 | 2019 |
Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation T Murakawa, O Yamaguchi, A Hashimoto, S Hikoso, T Takeda, T Oka, ... Nature communications 6 (1), 7527, 2015 | 434 | 2015 |
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases K Ishigaki, M Akiyama, M Kanai, A Takahashi, E Kawakami, H Sugishita, ... Nature genetics 52 (7), 669-679, 2020 | 366 | 2020 |
Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart K Yamamoto, T Masuyama, Y Sakata, N Nishikawa, T Mano, J Yoshida, ... Cardiovascular research 55 (1), 76-82, 2002 | 295 | 2002 |
Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy H Yamaguchi, J Yoshida, K Yamamoto, Y Sakata, T Mano, N Akehi, ... Journal of the American College of Cardiology 43 (1), 55-60, 2004 | 287 | 2004 |
JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis―Digest version― F Terasaki, A Azuma, T Anzai, N Ishizaka, Y Ishida, M Isobe, T Inomata, ... Circulation Journal 83 (11), 2329-2388, 2019 | 283 | 2019 |
Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry) N Sato, K Kajimoto, T Keida, M Mizuno, Y Minami, D Yumino, K Asai, ... Circulation journal 77 (4), 944-951, 2013 | 275 | 2013 |
Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting … Y Sakata, K Yamamoto, T Mano, N Nishikawa, J Yoshida, M Hori, T Miwa, ... Circulation 109 (17), 2143-2149, 2004 | 270 | 2004 |
Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease S Koyama, K Ito, C Terao, M Akiyama, M Horikoshi, Y Momozawa, ... Nature genetics 52 (11), 1169-1177, 2020 | 233 | 2020 |
Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension T Hashimoto-Kataoka, N Hosen, T Sonobe, Y Arita, T Yasui, T Masaki, ... Proceedings of the National Academy of Sciences 112 (20), E2677-E2686, 2015 | 233 | 2015 |
Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats R Doi, T Masuyama, K Yamamoto, Y Doi, T Mano, Y Sakata, K Ono, ... Journal of hypertension 18 (1), 111-120, 2000 | 200 | 2000 |
Safety and efficacy of autologous skeletal myoblast sheets (TCD-51073) for the treatment of severe chronic heart failure due to ischemic heart disease Y Sawa, Y Yoshikawa, K Toda, S Fukushima, K Yamazaki, M Ono, ... Circulation Journal 79 (5), 991-999, 2015 | 182 | 2015 |
Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction T Ohtani, SF Mohammed, K Yamamoto, SM Dunlay, SA Weston, Y Sakata, ... European heart journal 33 (14), 1742-1749, 2012 | 180 | 2012 |
Phase I clinical trial of autologous stem cell–sheet transplantation therapy for treating cardiomyopathy S Miyagawa, K Domae, Y Yoshikawa, S Fukushima, T Nakamura, A Saito, ... Journal of the American Heart Association 6 (4), e003918, 2017 | 177 | 2017 |
JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure H Tsutsui, T Ide, H Ito, Y Kihara, K Kinugawa, S Kinugawa, M Makaya, ... Circulation Journal 85 (12), 2252-2291, 2021 | 173 | 2021 |
AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure J Yoshida, K Yamamoto, T Mano, Y Sakata, N Nishikawa, M Nishio, ... Hypertension 43 (3), 686-691, 2004 | 169 | 2004 |
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial SJ Shah, BA Borlaug, ES Chung, DE Cutlip, P Debonnaire, PS Fail, ... The Lancet 399 (10330), 1130-1140, 2022 | 155 | 2022 |
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury Y Sakata, JW Dong, JG Vallejo, CH Huang, JS Baker, KJ Tracey, ... American Journal of Physiology-Heart and Circulatory Physiology 292 (1 …, 2007 | 155 | 2007 |